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Transmissible mink encepholapathy (TME) is a food-
borne transmissible spongiform encephalopathy (TSE) of 
ranch-raised mink; infection with a ruminant TSE has been 
proposed as the cause, but the precise origin of TME is 
unknown. To compare the phenotypes of each TSE, bo-
vine-passaged TME isolate and 3 distinct natural bovine 
spongiform encephalopathy (BSE) agents (typical BSE, H-
type BSE, and L-type BSE) were inoculated into an ovine 
transgenic mouse line (TgOvPrP4). Transgenic mice were 
susceptible to infection with bovine-passaged TME, typi-
cal BSE, and L-type BSE but not to H-type BSE. Based on 
survival periods, brain lesions proﬁ  les, disease-associated 
prion protein brain distribution, and biochemical properties 
of protease-resistant prion protein, typical BSE had a dis-
tint phenotype in ovine transgenic mice compared to L-type 
BSE and bovine TME. The similar phenotypic properties of 
L-type BSE and bovine TME in TgOvPrP4 mice suggest 
that L-type BSE is a much more likely candidate for the ori-
gin of TME than is typical BSE.
T
ransmissible mink encephalopathy (TME) is a rare 
prion disease in ranch-raised mink (Mustela vison) in 
North America and Europe (1–4). Six outbreaks have been 
reported from 1947 through 1985 in North America, and 
several have been linked to contaminated commercial feed 
(1). Although contamination of feed with scrapie-infected 
sheep parts has been proposed as the cause of TME, the 
origin of the disease remains elusive. The idea that scrapie 
in sheep may be a source of TME infection is supported by 
ﬁ  ndings that scrapie-infected mink have a similar distribu-
tion of vacuolar pathologic features in the brain and the 
same clinical signs as mink with natural and experimental 
TME (5). However, mink are not susceptible to scrapie in-
fection following oral exposure for up to 4 years postinocu-
lation, which suggests that either the scrapie agent may not 
be the source of natural TME infection or that only speciﬁ  c 
strains of the scrapie agent are able to induce TME (6,7).
Epidemiologic investigations in the Stetsonville, Wis-
consin, outbreak of TME in 1985 suggested a possible cat-
tle origin, since mink were primarily fed downer or dead 
dairy cattle but not sheep products (8). Experimental trans-
mission of Stetsonville TME into cattle resulted in trans-
missible spongiform encephalopathy (TSE) disease with an 
incubation period of 18.5 months. Back passage of bovine 
TME into mink resulted in incubation periods of 4 and 7 
months after oral or intracerebral inoculation, respective-
ly, which was similar to that found following inoculation 
of Stetsonville TME into mink by these same routes (8). 
These ﬁ  ndings indicated that cattle are susceptible to TME, 
and that bovine-passaged TME did not result in a reduced 
pathogenicity for mink. These studies raised the question 
as to whether an unknown TSE in cattle was the source of 
TME infection in the Stetsonville outbreak. Several addi-
tional TME outbreaks in the United States have been asso-
ciated with mink diet that contained downer or dead cattle 
(9). These TME outbreaks happened before bovine spongi-
form encephalopathy (BSE) was identiﬁ  ed in Europe or be-
fore 3 cases of BSE had occurred in the United States after 
Phenotypic Similarity of 
Transmissible Mink Encephalopathy 
in Cattle and L-type Bovine 
Spongiform Encephalopathy 
in a Mouse Model
Thierry Baron,* Anna Bencsik,* Anne-Gaëlle Biacabe,* Eric Morignat,* and Richard A. Bessen†
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 12, December 2007  1887 
*Agence Française de Sécurité Sanitaire des Aliments–Lyon, Lyon, 
France; and †Montana State University, Bozeman, Montana, USARESEARCH
2003. Despite a potential link of TME with a cattle TSE, 
clinical and histologic studies indicate that mink inoculated 
with BSE have features that distinguish this disease from 
natural and experimental TME (7,8,10).
Recent studies demonstrate, on the basis of the molec-
ular features of the protease-resistant prion protein (PrPres), 
that BSE has at least 3 different phenotypes in cattle (11). 
The cattle TSEs include: a) typical BSE, which is the prion 
strain identiﬁ  ed during the BSE epidemic in Europe during 
the 1980s; b) H-type BSE, which is an uncommon type that 
was originally found in France (12); and c) L-type BSE, 
also called bovine amyloidotic spongiform encephalopathy 
(BASE), which is a rare form of BSE ﬁ  rst identiﬁ  ed in Italy 
(13). More recently, the H-type and L-type BSEs have been 
shown to differ from typical BSE with respect to incubation 
periods, vacuolar pathologic changes in the brain, and bio-
chemical properties of PrPres in mice on transmission into 
wild-type or transgenic mice that express the bovine prion 
protein gene (14–18). The origin of these BSE cases is un-
known, but researchers have proposed that they represent 
a spontaneous form of TSE in cattle that is distinct from 
typical BSE; alternative hypotheses have also been consid-
ered, for example, cross-species contamination by another 
TSE source such as scrapie (15). If TME were to be due 
to infection with a cattle TSE, then these unusual forms of 
BSE are potential candidate agents since they may have a 
more widespread geographic distribution and were likely to 
precede the appearance of BSE in the USA.
In previous reports (19–22), to compare typical BSE 
and scrapie strains ruminants TSEs were transmitted into 
transgenic mice (TgOvPrP4) that overexpress the ovine 
prion gene (19–22). In the current study, we investigated 
the possible origins of TME by transmission of the bovine-
passaged Stetsonville TME agent into TgOvPrP4 mice, 
to compare the molecular and histopathologic features to 
those of typical and atypical BSE types. Our ﬁ  ndings indi-
cate that bovine TME is distinct from typical BSE and H-
type BSE but shares many features with L-type BSE. The 
implications of these ﬁ  ndings with respect to the origin of 
TME are discussed.
Materials and Methods
Cattle TSE Isolates
Cattle TSE isolates used in these studies included: a) 
the Stetsonville TME isolate experimentally-passaged into 
cattle as previously described (8); b) an L-type BSE iso-
late (02-2528) (11,13,23,24); c) a H-type BSE isolate (03-
2095) (12,14,17); and d) a typical BSE isolate (01-2281), 
for which transmission in TgOvPrP4 ovine transgenic mice 
was previously described (20). The typical, L-type, and H-
type BSE cases were diagnosed after active surveillance by 
rapid tests at rendering plants; the animals were 4, 8, and 
12 years of age at death, respectively. For a comparison of 
BSE transmission without a species barrier in ovine trans-
genic mice, a BSE isolate passaged in sheep (SB1) was also 
included in mouse transmissions studies (20,21).
Mouse Lines and Experimental Infections
The TgOvPrP4 mouse line expresses the ovine prion 
protein gene (A136R154Q171 genotype) in a PrP null mouse 
background as previously described (25). The ovine prion 
protein gene is 2–4× more important in a sheep brain of 
the same PrP genotype. Mice were cared for and housed 
according to the guidelines of the French Ethical Commit-
tee (decree 87-848) and European Community Directive 
86/609/EEC. Experiments were performed in the biohazard 
prevention area (A3) of the author’s institution with the ap-
proval of the Rhône-Alpes Ethical Committee for Animal 
Experiments.
Female mice, 4 to 6 weeks of age (6–12 animals per 
experimental group), were inoculated intracerebrally with 
10% (wt/vol) cattle brain homogenates in 5% glucose (20 
μL per animal). Brain specimens from TgOvPrP4 mice 
in which a TSE developed were subsequently passaged 
by intracerebral inoculation of a 1% (wt/vol) homogenate 
into a second group of transgenic mice. Mice were sacri-
ﬁ  ced at the terminal stage of disease, and the brains were 
collected and either analyzed for PrPres by Western blot 
or ﬁ  xed in buffered 4% paraformaldehyde for histopatho-
logic studies. Statistical analyses of survival periods were 
performed by using the log-rank test and the R software 
package (version 2.4.1); p values <0.05 were considered 
statistically signiﬁ  cant.
Western Blot Analyses of PrPres
PrPres was extracted from bovine brain stem samples 
by using the TeSeE Western blot Bio-Rad kit (Bio-Rad, 
Marnes-la-Coquette, France; Ref 355 1169) following the 
manufacturer’s instructions. Brieﬂ  y, 250 μL of 20% brain 
homogenates were incubated with an equal volume of re-
constituted proteinase K solution (reagent A + PK) at 37°C 
for 10 min. After addition of 250 μL of reagent B, samples 
were centrifuged at 15,000× g for 7 min. The pellets were 
resuspended in 50 μL of denaturing buffer (TD4215) (4% 
sodium dodecyl sulfate [SDS], 2% β-mercaptoethanol, 192 
mmol/L glycine, 25 mmol/L Tris, and 5% sucrose), heated 
for 5 min at 100°C, then centrifuged at 12,000× g for 15 
min. The pellets were discarded, and the supernatants were 
run on a 15% SDS–polyacrylamide gel (SDS-PAGE) be-
fore transfer to nitrocellulose membrane and immunoblot-
ting with anti-PrP antibodies. Western blot methods used 
to identify and characterize PrPres in TgOvPrP4 mice have 
been previously described (19,20). Brieﬂ  y, PrPres was ob-
tained after mouse brain homogenates were treated with 
proteinase K (Roche, Meylan, France) (10 μg/100 mg brain 
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tissue for 1 h at 37°C) and concentration by ultra-centrifu-
gation (100,000 g for 2 h on a 10% sucrose cushion). After 
denaturation in TD4215 buffer, PrPres was separated in 15% 
SDS-PAGE, electroblotted to nitrocellulose membranes, 
then detected on the membrane by using anti-PrP mono-
clonal antibodies.
PrPres was detected by using anti-PrP Bar233 mono-
clonal antibody (ascitic ﬂ   uid 1/10,000, provided by J. 
Grassi) or Sha31 (1/10 from kit TeSeE sheep/goat Bio-
Rad) against the ovine 152-FGSDYEDRYYRE-163 and 
156-YEDRYYRE-163 PrP sequences, respectively. Quan-
titative studies of PrPres polypeptide molecular mass and 
glycoforms proportions were performed by using Quantity 
One (Bio-Rad) software analysis of chemiluminescent sig-
nals following >3 independent runs of the samples from 
>3 different mice per experimental group. Glycoforms ra-
tios were expressed as mean percentages (± standard de-
viations) of the total signal for the 3 PrPres glycoforms and 
the apparent molecular masses were evaluated by compari-
son of the positions of the PrPres bands with a biotinylated 
marker (B2787; Sigma, St. Quentin Fallavier, France).
Histopathologic Analyses
Mouse brain ﬁ  xed in buffered 4% paraformaldehyde 
was treated for 1 h at room temperature with formic acid 
(98%–100%) before being embedded in parafﬁ  n blocks 
(Thermo Electron, Cergy-Pontoise, France). Tissue sec-
tions, 5 μm thick, were cut from parafﬁ  n blocks, placed on 
treated glass slides (Starfrost, Medite Histotechnic, Burg-
dorf, Germany), and dried overnight at 55°C. Once de-
waxed, slides were stained for either histopathologic or im-
munohistochemical examination. Amyloid deposits were 
identiﬁ  ed with a Congo red stain, and vacuolar lesions were 
observed on slides stained with hematoxylin-eosin (HE), 
according to Fraser’s lesion proﬁ  le analyses (26). Lesion 
proﬁ  les were measured by using a computer-assisted meth-
od (27). Brain slices were immunostained for the presence 
of disease-associated prion protein (PrPd) by using 2 μg/mL 
of anti-PrP SAF84 monoclonal antibody (SPI Bio, Massy, 
France). Recently described pre-treatments designed to 
enhance PrPd detection were also applied (28). These 
consisted of a 10-min formic acid (98%) bath at room tem-
perature, 20 min of hydrated autoclaving at 121°C (Pres-
tige Medical, AES Laboratories, Blackburn Lane, UK), and 
digestion at 37°C with proteinase K (Roche Diagnostics, 
Meylan, France) at a concentration of 20 μg/mL for 15 min, 
with an additional incubation with streptomycin sulfate at 
8.75 mmol/L for 1 h. Endogenous peroxidase activity was 
also blocked. A peroxidase-labeled avidin-biotin complex 
(Vectastain Elite ABC, Vector Laboratories, Burlingame, 
CA, USA) and a solution of diaminobenzidine intensiﬁ  ed 
with nickel chloride (DAB-Ni, Zymed, Montrouge, France) 
to give black deposits were used to amplify and visualize 
binding of the disease-associated form of PrP (PrPd). Final 
detection was achieved with a solution of diaminobenzidine 
intensiﬁ  ed with nickel chloride (DAB-Ni, Zymed) to give 
black deposits. The speciﬁ  city of PrPd immunolabeling was 
also assessed by using uninfected brain samples. Finally, 
the slides were counterstained with aqueous hematoxylin, 
dehydrated, mounted by using Eukitt mounting medium 
(VWR International, Limonest, France) and observed un-
der a light microscope BX51 (Olympus, Rungis, France) 
coupled to an image analysis workstation (MorphoExpert 
Software, Explora Nova, La Rochelle, France).
Results
Transmission of TSE Isolates in TgOvPrP4 Mice
To determine the ability of the 4 bovine TSE isolates 
(experimental bovine TME, L-type BSE, H-type BSE, and 
a typical BSE natural isolate) to cause a TSE in a common 
host species, they were inoculated into TgOvPrP4 mice 
(Table). The shortest survival period was observed in mice 
infected with the typical BSE isolate (421 ± 48 days), com-
pared with 436 ± 77 days or 627 ± 74 days in TgOvPrP4 
mice inoculated with bovine TME or L-type BSE, respec-
tively. At second serial passage of bovine TME, L-type BSE, 
and typical BSE into TgOvPrP4 mice, the survival periods 
were shortened for all 3 sources, but especially for L-type 
BSE (202 ± 26 days) and bovine TME (234 ± 27 days), 
although survival periods were statistically different for 
these 2 groups of mice (p = 0.0095). The survival period for 
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Table. TSE sources transmitted to TgOvPrP4 mice*
First passage  Second passage 
TSE sources  Nature 
Survival periods 
(mean ± SD dpi) 
No. PrP
dpositive 
mice/total†
Survival periods 
(mean ± SD dpi) 
No. PrP
dpositive 
mice/total†
Experimental isolates 
  TME  TME 436 ± 77  9/11 234 ± 27  9/9
  SB1  Ovine BSE  296 ± 46  19/19 365 ± 36  11/12
Natural isolates 
02-2528 L-type BSE                 627 ± 74  9/10 02 ± 26  9/9
  03-2095  H-type BSE  692 ± 129  0/8 ND ND
  01-2281  Typical BSE  421 ± 48  10/10 354 ± 48  10/10
*TSE, transmissible spongiform encephalopathy; dpi, days postinoculation; PrPP
d, disease-associated prion protein; TME, transmissible mink 
encephalopathy; BSE, bovine spongiform encephalopathy; ND, not done.
†Results obtained by Western blot or by immunohistochemical test. RESEARCH
typical BSE (354 ± 48 days) was signiﬁ  cantly longer than 
that found for L-type BSE and bovine TME (p<0.0001). 
For the ovine BSE isolate, the incubation period was 296 
± 46 days at ﬁ  rst passage, but the period increased to 365 
± 36 days at second passage. The survival period at second 
passage of ovine BSE was not signiﬁ  cantly different from 
that of typical BSE (p = 0.814). Most of the mice inoculated 
with the 3 bovine TSE isolates were positive (28/31 at ﬁ  rst 
passage) for PrPres by Western blot or PrPd by immunohis-
tochemical testing. In contrast, all (8/8) the transgenic mice 
inoculated with the H-type BSE isolate, which had a survival 
period of 692 ± 129 days, were negative for PrPres by either 
Western blot or PrPd by immunohistochemical analyses.
PrPres Molecular Features in Cattle and 
in TgOvPrP4 Mice
Western blot analysis of PrPres from bovine TME, L-
type BSE, H-type BSE, and typical BSE used for inocula-
tion into TgOvPrP4 mice was performed to compare the 
molecular features of PrPres. The bovine TME and L-type 
BSE isolates had similar molecular masses for the 3 PrPres 
polypeptides (Figure 1). The unglycosylated PrPres poly-
peptide has a similar molecular mass (≈18.5 kDa) in L-type 
BSE, bovine TME, and in typical BSE, whereas a differ-
ence in molecular mass (≈0.5–0.8 kDa lower) was found 
for the diglycosylated band in both L-type BSE and bovine 
TME compared to typical BSE. A comparison of PrPres 
glycoform ratios also showed similar proportions of the 
diglycosylated and monoglycosylated isoforms of PrPres 
in bovine TME and L-type BSE, both of which had lower 
levels of diglycosylated PrPres than in typical BSE (Figure 
2, panel A).
On transmission of the bovine TSE isolates to TgOv-
PrP4 mice, the L-type BSE differed from typical BSE in 
its lower proportion of diglycosylated PrPres, but the mo-
lecular masses of the unglycosylated PrPres polypeptides 
were similar between these isolates (Figure 2, panel B, and 
Figure 3, panel A). In contrast, Western blot analysis of 
PrPres showed indistinguishable patterns in transgenic mice 
infected with the L-type BSE or bovine TME, with respect 
to the molecular mass of the 3 PrPres polypeptides (Figure 
3, panel B) and the ratio of these PrPres glycoforms (Figure 
2, panel C). These comparable features were maintained 
in both L-type BSE and bovine TME at second passage in 
TgOvPrP4 mice (Figure 2, panel D, and Figure 3, panel C), 
and these were distinct from typical BSE, on the basis of 
the ratio of the 3 PrPres glycoforms.
Histopathologic Features of TME in Cattle 
and L-type BSE in TgOvPrP4 Mice
To further examine the phenotypes of the bovine TSE 
agents, the distribution of vacuolar lesions and the distribu-
tion and features of PrPd were investigated at standardized 
brain levels of TgOvPrP4 mice (Figure 4). TgOvPrP4 mice 
infected with L-type BSE at ﬁ  rst passage showed low vac-
uolar lesion intensity but PrPd accumulation was strongly 
detected, which was characterized by PrPd aggregation into 
plaques. These plaques were not amyloid based on an ab-
sence of Congo red birefringence (data not shown). At the 
second passage, L-type BSE agent induced a lower degree 
of PrPd accumulation than in the ﬁ  rst passage; the type of 
deposition was ﬁ  ne powdery to granular, and no plaques 
were observed. Although the brain lesion proﬁ  le showed a 
higher degree of vacuolation than in the ﬁ  rst passage, the 
PrPd mapping was similar at ﬁ  rst and second passage in 
transgenic mice. At second passage, some additional sites 
had PrPd accumulation, including the septal areas and the 
midbrain. The L-type BSE remained distinct from typical 
BSE, in terms of lesion proﬁ  les and types of PrPd deposi-
tion. In the brain of TgOvPrP4 mice infected with typical 
BSE and ovine BSE, numerous ﬂ  orid plaques containing 
PrPd were seen, and these were amyloid, based on Congo 
red staining. The ﬂ  orid plaques were prominent in the cor-
tical regions of the brain in transgenic mice infected with 
typical BSE but were not found in any of the mice infected 
with L-type BSE at either ﬁ  rst or second passage. At second 
passage, vacuolar changes were more intense in the dorsal 
medulla nuclei, hypothalamus, and hippocampus in mice 
infected with typical BSE; in L-type BSE-infected mice, 
lesions were more pronounced in the colliculus, thalamus, 
and cerebral cortex.
The distribution of vacuolar changes and PrPd in the 
brain of TME-infected mice was similar to that observed in 
mice infected with L-type BSE, although minor differences 
in the PrPd immunolabeling intensities were found in some 
brain regions, including the absence of the ﬁ  ne, powdery 
PrPd in the caudate putamen of bovine TME-infected mice. 
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Figure 1. Western blot analyses of protease-resistant prion 
protein from proteinase K–treated brain homogenates from cattle 
transmissible spongiform encephalopathies (TSEs). Typical bovine 
spongiform encephalopathy (BSE) (lanes 1, 5), L-type BSE (lane 
2), transmissible mink encephalopathy (TME) in cattle (lane 3), 
H-type BSE (lane 4). Bars to the left of the panel indicate the 29.0- 
and 20.1-kDa marker positions.Similarities of TME and L-type BSE
It is noteworthy that the PrPd distribution was also com-
parable in transgenic mice infected with bovine TME and 
typical BSE; however, no ﬂ  orid plaques were detected in 
any of the mice infected with bovine TME.
Discussion
Comparison of TME and 3 distinct types of BSE in a 
common host species was prompted by previous observa-
tions that TME, whose origin is unknown, did not reduce 
its pathogenicity for mink after passage into cattle (8), and 
transmission of TME into cattle resulted in a low-molecu-
lar-mass PrPres proﬁ  le (29). A similar low-molecular-mass 
PrPres proﬁ  le has been observed in L-type BSE or BASE 
(11,13,16), and in the current study, these similar PrPres mo-
lecular properties between bovine TME and L-type BSE 
were demonstrated in TgOvPrP4 mice. These 2 distinct bo-
vine TSE sources were both readily transmitted into TgOv-
PrP4 mice (illustrating the usefulness of transgenic mouse 
models for prion agent strain typing when transmission to a 
common wild-type rodent is not possible) and had several 
common features including survival periods, PrPres molec-
ular features, and the distribution of vacuolar pathologic 
changes. This combination of biochemical and phenotypic 
properties indicates that they have similar biologic prop-
erties in TgOvPrP4 mice and could represent independent 
isolation of the same TSE strain, although some subtle his-
tologic differences between L-type BSE and bovine TME 
were observed on second passage in TgOvPrP4 mice. Ad-
ditional serial passages from these cattle TSE sources are 
required for further characterization, especially since the 
possibility cannot be excluded that transmission of a cattle 
TSE into mink can modify its biologic properties.
In contrast, transmission of L-type BSE and typical 
BSE into TgOvPrP4 mice resulted in different incubation 
periods, PrPres molecular properties, and histopathologic 
features during 2 serial passages. The survival period at 
second passage for L-type BSE was considerably reduced 
and signiﬁ  cantly shorter (>120 days) than typical BSE after 
2 passages into TgOvPrP4 mice. Although ﬂ  orid plaques 
were found in transgenic mice infected with typical BSE, 
they were not observed in mice following ﬁ  rst or second 
passage of L-type BSE in TgOvPrP4 mice. Analysis of 
PrPres properties also found differences between L-type and 
typical BSE with respect to the relative proportion of digly-
cosylated PrPres polypeptides. The lower molecular mass of 
the unglycosylated PrPres polypeptide in L-type BSE was 
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Figure 2. Glycoforms proportions (means ± standard deviations) of protease-resistant prion protein  detected by using Sha31 antibody. 
A) Cattle transmissible spongiform encephalopathies (TSEs). B) First passage of L-type and typical bovine spongiform encephalopathy 
(BSE) into TgOvPrP4 mice. C) First passage of transmissible mink encephalopathy (TME) in cattle and L-type BSE into TgOvPrP4 mice. 
D) Second passage of TME in cattle and L-type BSE into TgOvPrP4 mice. Results from 3 individual mice from each experimental group 
are shown. Typical BSE in red, H-type BSE in yellow, L-type BSE in green, and TME-in-cattle in blue.RESEARCH
maintained in TgOvPrP4 mice as well as in typical BSE. 
In cattle, the size of the unglycosylated PrPres polypeptide 
in L-type BSE is within the range of that found in typical 
BSE (16). Notably, our ﬁ  ndings did not produce evidence 
for modiﬁ  cation of the phenotypic features of these cattle 
TSEs on passage into TgOvPrP4 mice, which was recently 
described after transmission of L-type BSE into wild-type 
(18) or tg338 ovine transgenic (24) mice.
The current and previous studies demonstrate that 
when typical BSE and L-type BSE are transmitted into 
TgOvPrP4 mice, key features of these cattle TSEs were 
maintained (19–21). However, these transgenic mice were 
not susceptible to the H-type BSE, as conﬁ  rmed with 4 oth-
er isolates (data not shown). This ﬁ  nding is in contrast to 
a previous study that demonstrated transmission of H-type 
BSE into a different transgenic mouse line expressing the 
ovine prion protein gene (15). Possible explanations for this 
discrepancy are the lower level of the cellular prion protein 
in TgOvPrP4 mice compared with tg338 mice (2- to 4-fold 
vs. 8- to 10-fold greater than ovine brain), different cellular 
patterns of expression due to the use of different promoters, 
or the different sequence of the prion gene (V136R154Q171 in 
tg338 mice) (20,30). These ﬁ  ndings on the transmission of 
H-type into transgenic mice provide further evidence for 
the distinct biologic properties of this cattle TSE compared 
to L-type BSE and typical BSE.
The Stetsonville isolate of TME that was experi-
mentally passaged into cattle was also readily transmit-
ted into TgOvPrP4 mice and resulted in a TSE phenotype 
that shared common biologic features with L-type BSE, 
but not typical BSE, in these transgenic mice. Transmis-
sion of TME from temporally and geographically different 
outbreaks into cattle showed that bovine TME is similar 
among the different isolates but all of them are phenotypi-
cally distinct from typical BSE (7). Histopathologic stud-
ies showed more severe spongiform changes, especially at 
rostral levels, in cattle infected with TME (7) than infected 
with typical BSE, and these changes were also observed in 
TgOvPrP4 mice infected with L-type BSE at second pas-
sage. Conversely, mink infected with typical BSE had a 
greater degree of spongiform change in the brainstem than   
mink infected with TME (10). Similar changes were also 
observed in TgOvPrP4 mice infected with typical BSE. 
This preferential involvement of rostral brain regions in 
L-type BSE has also been described in cattle (13) and on 
transmission into bovine transgenic mice (18,24). Trans-
mission of TME or typical BSE into wild-type mice (31,32) 
or hamsters (33,34) also resulted in distinct transmissibil-
ity between these TSEs in these host species. Based on 
these ﬁ  ndings, we conclude that typical BSE is not a likely 
source for TME in mink; however, if TME were to be due 
to infection with a cattle TSE, the most likely candidate is 
L-type BSE.
L-type BSE has not been reported in the United States, 
although importation of cattle or cattle products with a TSE 
infection cannot be excluded as a potential source. Recent-
ly, 2 BSE cases identiﬁ  ed in cattle born in the United States 
had unusual PrPres properties similar to those described for 
H-type BSE (11,12,35,36), which raised the possibility that 
atypical TSEs in cattle may be a source for TME infection. 
In Europe, the prevalence of the H-type or L-type BSE is 
estimated to be very low (in France the L-type BSE occurs 
at a prevalence of 1 case found PrPres positive in the brain 
stem per 3 million cattle tested per year) (23). The very rare 
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Figure 3. Western blot of protease-resistant prion protein from 
TgOvPrP4 mice after proteinase K digestion and immunodetection 
with anti-PrP Sha31 antibody. A) First passage of typical bovine 
spongiform encephalopathy (BSE) (lanes 2, 4, and 6) and L-type 
BSE (lanes 3, 5, and 7). B) First passage of TME in cattle (lanes 
2, 4, and 6) and L-type (lanes 3, 5, and 7). C) Second passage of 
TME in cattle (lanes 2, 4, and 6) and L-type BSE (lanes 3, 5, and 
7). Each lane shows PrPres from a distinct individual mouse from 
each experimental group. Bars to the left of the panel indicate the 
29.0- and 20.1-kDa marker positions. Lane 1, PrPres control from a 
scrapie-infected TgOvPrP4 mouse (C506M3 strain).Similarities of TME and L-type BSE
prevalence of TME may be partially due to the rare occur-
rence of cattle TSEs that enter the mink diet (8,29).
Conclusion
These studies provide experimental evidence that the 
Stetsonville TME agent is distinct from typical BSE but 
has phenotypic similarities to L-type BSE in TgOvPrP4 
mice. Our conclusion is that L-type BSE is a more likely 
candidate for a bovine source of TME infection than typi-
cal BSE. In the scenario that a ruminant TSE is the source 
for TME infection in mink, this would be a second example 
of transmission of a TSE from ruminants to non-ruminants 
under natural conditions or farming practices in addition to 
transmission of typical BSE to humans, domestic cats, and 
exotic zoo animals (37). The potential importance of this 
ﬁ  nding is relevant to L-type BSE, which based on experi-
mental transmission into humanized PrP transgenic mice 
and macaques, suggests that L-type BSE is more pathogen-
ic for humans than typical BSE (24,38).
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